India, Sept. 28 -- Platelet rich plasma (PRP) therapy is emerging as a promising approach in reproductive medicine, especially for women with declining ovarian reserve due to age. PRP is prepared from the patient's own blood, which is processed to concentrate platelets rich in growth factors and cytokines. When injected into the ovaries, these bioactive substances are believed to stimulate dormant follicles, improve blood supply, and enhance ovarian function. For women with poor ovarian response or low egg count, PRP offers a ray of hope by potentially restoring fertility and improving outcomes in IVF. For patients with premature menopause, it can help in restoring menstruation by rejuvenating follicles, thus providing much required hormonal support for woman's well-being. While research is still ongoing and results may vary, early studies and clinical experiences suggest encouraging possibilities. PRP therapy is minimally invasive, safe, and uses the body's own natural healing potential. It represents a hopeful step toward extending reproductive options for women with aging ovaries, offering them renewed chances of conceiving with their own eggs. The author of the article is an IVF and fertility specialist at Jindal IVF, SCO 21, Sector 20-D, Dakshin Marg, Chandigarh, who can be contacted at 958-246-9429....